A young life lost, a community in shock, and a call for change. The tragic death of 18-year-old Meg Draper from meningitis B has sparked a crucial conversation about vaccination policies and the protection of young adults.
The Shocking Diagnosis: Meg, a vibrant and athletic student, had just begun her physiotherapy studies at Bournemouth University when she suddenly fell ill. Within 24 hours, her symptoms escalated, including fever, headache, vomiting, and a rash on her stomach. But here's where it gets controversial: despite her vaccination history, Meg had contracted meningitis B, a strain not covered by the routine meningitis vaccine she received at 14.
The Meningitis Threat: Meningitis is a severe infection causing swelling of the brain and spinal cord tissues. It's highly contagious, spreading like the common cold through sneezing and coughing. University students are particularly vulnerable due to their social interactions. The bacteria can lead to life-threatening complications, including septicaemia, brain damage, and even death.
The Vaccine Dilemma: The MenB vaccine, the only defense against this deadly strain, is currently only offered on the NHS to young children, deemed most at risk. But why not older children and young adults? The vaccine's protection wanes over time, and a booster or vaccine for older children costs £220 privately. This leaves a significant gap in protection for teenagers, who are more likely to carry the bacteria in their throats, leading to a second peak in cases.
A Family's Plea: Meg's parents, devastated by their loss, are now advocating for change. They argue that the vaccine should be made available to young adults on the NHS, ensuring protection for those at risk. They believe Meg's death could have been prevented with better awareness and access to the vaccine.
The Official Response: The Welsh government, guided by the Joint Committee on Vaccination and Immunisation (JCVI), maintains that a routine jab for young adults is not cost-effective. However, the National Union of Students UK and charity Meningitis Now disagree, emphasizing the vaccine's potential to save lives and keep families together.
The Impact on Campus: Meg's death has deeply affected her university community. Her friends and flatmates, who attended her funeral in large numbers, are now grappling with the reality of this preventable tragedy. Bournemouth University has been proactive in offering advice and reminders about meningitis vaccination, but the question remains: is it enough?
A Call to Action: This story highlights the importance of meningitis awareness and the need for accessible vaccines. Should young adults be prioritized for the MenB vaccine? Are current policies sufficient to protect students? Share your thoughts and let's keep the conversation going to honor Meg's memory and prevent future tragedies.
